Security key
98420P308
Xtant Medical Holdings, Inc. - Common Stock (XTNT)
CUSIP: 98420P308
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 81,404,745
- Total 13F value
- $63,818,481
- Share change
- +957,092
- SEC-reported price per share
- $0.78
- Number of holders
- 35
- Value change
- +$760,014
- Number of buys
- 14
- Number of sells
- 15
- Shares outstanding
- 140,036,400
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
35
Top holders
10
XTNT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2026
Previous quarter: Q3 2025
Xtant Medical Holdings, Inc. SEC filings
Xtant Medical Holdings, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 98420P308
Recent filing periods:
Ownership snapshot
Top reported holders of XTNT - Xtant Medical Holdings, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Nantahala Capital Managem...
Disclosed value leader
Nantahala Capital Managem...
Comparable rows
15/15
Latest evidence
31 Dec 2025
13D/G
3/4/5
13F
Lead comparable stake: 49%
13D/G row: Nantahala Capital Management, LLC
Showing 1-6 of 15 holder rows.
Quick read
Nantahala Capital Management, LLC leads the comparable SEC ownership view at 49%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Nantahala Capital Management, LLC's linked filing trail.
Comparable ownership
Top 5
Nantahala Capital Management, LLC
49%
Laurence W. Lytton
5.5%
Stavros G. Vizirgianakis
5.4%
Jonn R. Beeson
1.1%
John K. Bakewell
0.65%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC |
13D/G
3/4/5
13F
10%+ Owner · Company
|
49%
|
$50,543,166
68,394,000 shares
|
$0 | 01 Aug 2025 |
| Laurence W. Lytton |
13D/G
LYTTON LAURENCE W
|
5.5%
|
$5,545,441
7,702,002 shares
|
-$1,268,237 | 31 Dec 2025 |
| Stavros G. Vizirgianakis |
3/4/5
Director
|
5.4%
|
$5,786,988
7,515,570 shares
|
— | 15 Nov 2025 |
| Jonn R. Beeson |
3/4/5
Director
|
1.1%
|
$1,180,325
1,532,891 shares
|
— | 15 Nov 2025 |
| John K. Bakewell |
3/4/5
Director
|
0.65%
|
$703,869
914,116 shares
|
— | 15 Nov 2025 |
| Abhinav Jain |
3/4/5
Director
|
0.11%
|
$121,835
158,228 shares
|
— | 15 Nov 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
35
Shares
81,404,745
Rows available
35
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
29
Q4 2025 holders
35
Holder diff
6
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend